Citation: R. Raju et al., Acetylcholine receptor peptide recognition in HLA DR3-transgenic mice: In vivo responses correlate with MHC-peptide binding, J IMMUNOL, 167(2), 2001, pp. 1118-1124
Authors:
Forsthuber, TG
Shive, CL
Wienhold, W
de Graaft, K
Spack, EG
Sublett, R
Melms, A
Kort, J
Racke, MK
Weissert, R
Citation: Tg. Forsthuber et al., T cell epitopes of human myelin oligodendrocyte glycoprotein identified inHLA-DR4 (DRBI0401) transgenic mice are encephalitogenic and are presentedby human B cells, J IMMUNOL, 167(12), 2001, pp. 7119-7125
Authors:
Shime, N
Sawa, T
Fujimoto, J
Faure, K
Allmond, LR
Karaca, T
Swanson, BL
Spack, EG
Wiener-Kronish, JP
Citation: N. Shime et al., Therapeutic administration of anti-PcrV F(ab ')(2) in sepsis associated with Pseudomonas aeruginosa, J IMMUNOL, 167(10), 2001, pp. 5880-5886
Authors:
Howard, MC
Spack, EG
Choudhury, K
Greten, TF
Schneck, JP
Citation: Mc. Howard et al., MHC-based diagnostics and therapeutics - clinical applications for disease-linked genes, IMMUNOL TOD, 20(4), 1999, pp. 161-165
Authors:
Nagvekar, N
Corlett, L
Jacobson, LW
Matsuo, H
Chalkley, R
Driscoll, PC
Deshpande, S
Spack, EG
Willcox, N
Citation: N. Nagvekar et al., Scanning a DRB30101 (DR52a)-restricted epitope cross-presented by DR3: Overlapping natural and artificial determinants in the human acetylcholine receptor, J IMMUNOL, 162(7), 1999, pp. 4079-4087